148 related articles for article (PubMed ID: 36401298)
1. Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey.
Syros A; Rodriguez MG; Rennick AC; Dima GA; Gibstein AR; de la Parte L; Hermenau MG; Ciraldo KJ; Chueng TA; Tookes HE; Bartholomew TS; Serota DP
Addict Sci Clin Pract; 2022 Nov; 17(1):63. PubMed ID: 36401298
[TBL] [Abstract][Full Text] [Related]
2. Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden.
Kazerouni NJ; Irwin AN; Levander XA; Geddes J; Johnston K; Gostanian CJ; Mayfield BS; Montgomery BT; Graalum DC; Hartung DM
Drug Alcohol Depend; 2021 Jul; 224():108729. PubMed ID: 33932744
[TBL] [Abstract][Full Text] [Related]
3. Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states.
Hill LG; Loera LJ; Torrez SB; Puzantian T; Evoy KE; Ventricelli DJ; Eukel HN; Peckham AM; Chen C; Ganetsky VS; Yeung MS; Zagorski CM; Reveles KR
Drug Alcohol Depend; 2022 Aug; 237():109518. PubMed ID: 35691255
[TBL] [Abstract][Full Text] [Related]
4. Understanding the role of community pharmacies in current medication for opioid use disorder care practices.
Comanici KH; Nichols MA; Scott C; Conklin M; Ott CA; Arnett S; Karwa R
J Am Pharm Assoc (2003); 2023; 63(1):261-268.e2. PubMed ID: 36209034
[TBL] [Abstract][Full Text] [Related]
5. Treatment access for opioid use disorder among women with medicaid in Florida.
Elmore AL; Patrick SW; McNeer E; Fryer K; Reid CN; Sappenfield WM; Mehra S; Salemi JL; Marshall J
Drug Alcohol Depend; 2023 May; 246():109854. PubMed ID: 37001322
[TBL] [Abstract][Full Text] [Related]
6. Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA.
Hill LG; Loera LJ; Evoy KE; Renfro ML; Torrez SB; Zagorski CM; Perez JC; Jones SM; Reveles KR
Addiction; 2021 Jun; 116(6):1505-1511. PubMed ID: 33140519
[TBL] [Abstract][Full Text] [Related]
7. Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.
Jarrett JB; Bratberg J; Burns AL; Cochran G; DiPaula BA; Legreid Dopp A; Elmes A; Green TC; Hill LG; Homsted F; Hsia SL; Matthews ML; Ghitza UE; Wu LT; Bart G
Subst Abus; 2023 Oct; 44(4):264-276. PubMed ID: 37902032
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.
Raisch DW; Fudala PJ; Saxon AJ; Walsh R; Casadonte P; Ling W; Johnson BA; Malkerneker U; Ordorica P; Williford WO; Sather MR
J Am Pharm Assoc (2003); 2005; 45(1):23-32. PubMed ID: 15730114
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting.
Morgan JR; Barocas JA; Murphy SM; Epstein RL; Stein MD; Schackman BR; Walley AY; Linas BP
JAMA Netw Open; 2020 Dec; 3(12):e2029676. PubMed ID: 33320266
[TBL] [Abstract][Full Text] [Related]
10. 'Red Flags' and 'Red Tape': Telehealth and pharmacy-level barriers to buprenorphine in the United States.
Textor L; Ventricelli D; Aronowitz SV
Int J Drug Policy; 2022 Jul; 105():103703. PubMed ID: 35561484
[TBL] [Abstract][Full Text] [Related]
11. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
Andraka-Christou B; Atkins D
Am J Drug Alcohol Abuse; 2020 Nov; 46(6):749-760. PubMed ID: 32969757
[TBL] [Abstract][Full Text] [Related]
12. Ensuring buprenorphine access in rural community pharmacies to prevent overdoses.
Ostrach B; Potter R; Wilson CG; Carpenter D
J Am Pharm Assoc (2003); 2022; 62(2):588-597.e2. PubMed ID: 34674965
[TBL] [Abstract][Full Text] [Related]
13. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
Smith A; Hansen J; Colvard M
J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
[TBL] [Abstract][Full Text] [Related]
14. Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
Peckham AM; Ball J; Colvard MD; Dadiomov D; Hill LG; Nichols SD; Tallian K; Ventricelli DJ; Tran TH
Am J Health Syst Pharm; 2021 Mar; 78(7):613-618. PubMed ID: 33411894
[TBL] [Abstract][Full Text] [Related]
15. Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia.
Trull G; Major E; Harless C; Zule W; Ostrach B; Carpenter D
Explor Res Clin Soc Pharm; 2021 Dec; 4():100082. PubMed ID: 35479845
[TBL] [Abstract][Full Text] [Related]
16. Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis.
Solomon KT; Bandara S; Reynolds IS; Krawczyk N; Saloner B; Stuart E; Connolly E
J Subst Abuse Treat; 2022 Jan; 132():108424. PubMed ID: 34144299
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
[TBL] [Abstract][Full Text] [Related]
18. Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge.
Roy PJ; Price R; Choi S; Weinstein ZM; Bernstein E; Cunningham CO; Walley AY
Drug Alcohol Depend; 2021 Jul; 224():108703. PubMed ID: 33964730
[TBL] [Abstract][Full Text] [Related]
19. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder.
DeRonne BM; Wong KR; Schultz E; Jones E; Krebs EE
Am J Health Syst Pharm; 2021 Feb; 78(4):354-359. PubMed ID: 33326564
[TBL] [Abstract][Full Text] [Related]
20. Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes.
Khan A; Khan Q; Kolb E
J Subst Abuse Treat; 2021 Apr; 123():108256. PubMed ID: 33612191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
